Global Market Access for Innovative Therapies, Treatments & Diagnostics
Navigating market access for innovative therapies has become increasingly complex due to tighter healthcare budgets, a more competitive pharmaceutical landscape, and varying regulations across countries. Early planning is essential and requires the support of experts who understand the specific challenges and decision-making criteria in health technology assessments.
Programs we support:
- Managed Access Program(s)
- Patient Access Program(s) or Named Patient Program(s)
- Early Access Program(s)
- Expanded Access Program(s)
- Compassionate Use Program(s)
Our Service & How we benefit our customers:
Implementing a Managed Access program can be unpredictable.
Despite meticulous planning, pharmaceutical and biotech companies often face uncertainty about demand, patient access requests, and program scale.
The first request might come from a patient outside the initial scope, demand may differ from forecasts, and the program scope may need to adjust with the global commercial roll-out.
Pharmaceutical and biotech companies need a partner who can do more than just execute the plan. They need a partner with the capability, experience, and resources to adapt and ensure no eligible patient goes without treatment.
With over 15 years of experience across 100+ programs, Jupiter Research Services helps pharmaceutical and biotech companies navigate this dynamic global environment.
Boasting the industry’s largest team focused on early access and expertise in supplying 50+ countries, Jupiter Research Services ensures the right medicine reaches the right patient at the right time.
Getting early access right is critical, which is why pharmaceutical and biotech companies trust Jupiter Research Services.
Our Managed Access Program
Pratik Shah
A Geneticist by Education, Clinical Researcher by Specialization, and A meticulous professional with diverse career span encompassing clinical research, clinical trial management, project management, supply chain management and CMC & Regulatory Affairs, Mr. Pratik Shah works with physicians globally and liaise with the manufacturers to enable them to ensure “Right Medication to Right Patient at Right Time within Right Conditions”.
Managed Access Supply Chain
Worldwide Reach: International & National, Global & Local Our clients: including pharmaceutical, biopharmaceutical, therapeutics companies, and Patients benefit from our sustained investment in the people, locations, partnerships and technology that make us a truly global business:
- High quality wholly owned & integrated distribution chain
- Program and product/brand managers based ‘in region’
- Global and Local network of suppliers and supply chain partners to enable us accessing “difficult” & “controlled” access products
- Patient Level Support
- 50+ countries shipped to in the last 24 months
- 1,100+ employees providing support and expertise from 14 offices
In addition to global services, effective commercialization and access requires footprint, resources and regional expertise in a particular territory – Jupiter Research Services should be your partner of choice for any elements that you cannot perform in-house.